Clinical Trials in Philadelphia

Showing 16821-16840 of 20,904 trials

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

NCT00326664

This phase I trial is studying the side effects and best dose of AZD2171 in treating young patients with recurrent, progressive, or refractory primary CNS tumors. AZD2171 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+18 more

National Cancer Institute (NCI)55 participantsStarted Mar 2006

San Francisco, California, United States • Washington D.C., District of Columbia, United States • Chicago, Illinois, United States +8 more locations

TERMINATEDPhase 2< 1 mile

[124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint

NCT01705496

This protocol will evaluate the sensitivity and specificity of \[124I\]FIAU as a diagnostic imaging agent for the detection of prosthetic joint infections in patients.

Prosthetic Joint Infections

BioMed Valley Discoveries, Inc23 participantsStarted Aug 2012

Mobile, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +7 more locations

AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors

[124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint

Find Trials by Condition in Philadelphia

Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma

Adjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast Cancer

Pharmacogenetics of Nicotine Addiction Treatment

Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Enrolled in a Methadone Maintenance Treatment Program.

PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer

Multi-site Decision Impact Study for Decipher

Glucose Meter Study

A Two Arm, Multi-Centre Clinical Evaluation of the NxTAG Respiratory Pathogen Panel

A Multi-Site Clinical Evaluation of the ARIES Flu Assay in Symptomatic Patients

Sorafenib + Topotecan for Platinum-Resistant Recurrent Ovarian Cancer

Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

ProMRI PROVEN Master Study